Managers / Q3 2025 · view latest →
Corsicana & Co.
CIK 0001869923 · 321 N. 15TH STREET, CORSICANA, TX, 75110 · 9036414503
Summary
Corsicana & Co. reported $178M in U.S.-listed holdings across 261 positions for Q3 2025.
Its largest position, Ishares Russell 2000 Etf, represents 6.4% of the portfolio.
Compared with Q3 2022, the fund opened 87 new positions and exited 35.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 52.1% · $93M
- ETP · 44.5% · $79M
- REIT · 2.4% · $4M
- MLP · 0.7% · $1M
- ADR · 0.3% · $503,517
- Other · 0.0% · $19,398
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline) · note: prior filed quarter, not the immediately preceding one
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| iShares Core S&P 500 ETF | NEW | +6.5K | 6.5K | +$4M | $4M |
| Vanguard Small-Cap ETF | NEW | +4.0K | 4.0K | +$1M | $1M |
| NDQInvesco QQQ Trust, Series 1 | NEW | +1.2K | 1.2K | +$720,444 | $720,444 |
| UNHUnitedHealth Group Inc | NEW | +1.5K | 1.5K | +$517,259 | $517,259 |
| RNAGBPAvidity Biosciences, Inc. | NEW | +8.0K | 8.0K | +$348,560 | $348,560 |
| GE Aerospace | NEW | +686 | 686 | +$206,363 | $206,363 |
| PLTRPalantir Technologies | NEW | +1.0K | 1.0K | +$182,420 | $182,420 |
| VUGVanguard Growth ETF | NEW | +277 | 277 | +$132,852 | $132,852 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $158M | 276 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $178M | 259 | Jan 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $178M | 261 | Oct 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $119M | 209 | Oct 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $126M | 212 | Jul 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $154M | 212 | Apr 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $165M | 210 | Jan 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $157M | 211 | Oct 7, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $158M | 202 | Jul 1, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.